Parallel Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$563K Sell
7,904
-287
-4% -$22.6K 0.01% 681
2025
Q4
$672K Buy
8,191
+389
+5% +$30.3K 0.01% 580
2025
Q3
$586K Buy
7,802
+562
+8% +$41.9K 0.01% 603
2025
Q2
$536K Sell
7,240
-307
-4% -$21.4K 0.01% 603
2025
Q1
$609K Buy
7,547
+412
+6% +$35.4K 0.01% 519
2024
Q4
$558K Buy
7,135
+135
+2% +$11.5K 0.01% 560
2024
Q3
$657K Buy
7,000
+583
+9% +$48.9K 0.02% 486
2024
Q2
$500K Sell
6,417
-354
-5% -$28.9K 0.01% 536
2024
Q1
$616K Buy
6,771
+781
+13% +$65K 0.02% 471
2023
Q4
$463K Sell
5,990
-543
-8% -$38K 0.01% 511
2023
Q3
$445K Buy
6,533
+1,714
+36% +$125K 0.01% 489
2023
Q2
$392K Buy
4,819
+832
+21% +$66.4K 0.01% 536
2023
Q1
$327K Buy
+3,987
New +$285K 0.01% 580

Other funds holding GEHC

Parallel Advisors's GEHC Position: Q1 2026 in Review

Parallel Advisors reduced its GE HealthCare (GEHC) stake by 3.5% in Q1 2026, selling an estimated $22.6K and leaving 7,904 shares worth $563K. The position accounts for 0.01% of the portfolio, ranked #681.

Parallel Advisors first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $672K in Q4 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Parallel Advisors held 7,904 shares of GE HealthCare worth $563K as of Q1 2026.
  • Parallel Advisors sold 287 GE HealthCare shares in Q1 2026, an estimated $22.6K.
  • GE HealthCare made up 0.01% of Parallel Advisors's portfolio in Q1 2026, its #681 holding.
  • Parallel Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Parallel Advisors's GE HealthCare position peaked at $672K in Q4 2025.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.